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Abstract
Glutathione transferases (GSTs) are dimeric enzymes containing one active-site per monomer. The omega-class GSTs
(hGSTO1-1 and hGSTO2-2 in humans) are homodimeric and carry out a range of reactions including the glutathione-
dependant reduction of a range of compounds and the reduction of S-(phenacyl)glutathiones to acetophenones. Both
types of reaction result in the formation of a mixed-disulfide of the enzyme with glutathione through the catalytic
cysteine (C32). Recycling of the enzyme utilizes a second glutathione molecule and results in oxidized glutathione
(GSSG) release. The crystal structure of an active-site mutant (C32A) of the hGSTO1-1 isozyme in complex with GSSG
provides a snapshot of the enzyme in the process of regeneration. GSSG occupies both the G (GSH-binding) and H
(hydrophobic-binding) sites and causes re-arrangement of some H-site residues. In the same structure we demonstrate
the existence of a novel ‘‘ligandin’’ binding site deep within in the dimer interface of this enzyme, containing S-(4-
nitrophenacyl)glutathione, an isozyme-specific substrate for hGSTO1-1. The ligandin site, conserved in Omega class GSTs
from a range of species, is hydrophobic in nature and may represent the binding location for tocopherol esters that are
uncompetitive hGSTO1-1 inhibitors.
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Introduction
The inducible phase II enzymes known as glutathione
transferases (GSTs; E.C. 2.5.1.18) conjugate endogenous and
xenobiotic toxins with electrophilic centers to glutathione (c-glu-
cys-gly, GSH). Several classes function as glutathione peroxidases
or as reductases [1]. Among the human isozymes are the
cytoplasmic alpha, zeta, theta, mu, pi, sigma and omega classes.
The most recently described family in humans is omega: two
isozymes have been identified (designated hGSTO1-1 and
hGSTO2-2) [2,3]. The Omega class GSTs are associated with
biological processes including the modulation of ryanodine
receptors [4] and the activation of IL-1b [5]. Polymorphisms in
the Omega class GSTs have been associated with the age at onset
of Alzheimer’s and Parkinson’s diseases [6], familial amyotrophic
lateral sclerosis [7], and the development of acute childhood
lymphoblastic leukemia [8].
Like all cystosolic GSTs, the omega-class isozymes have an N-
terminal thioredoxin-like domain and a unique helical C-terminal
domain [9,10]. The active sites of most GSTs contain a serine or
tyrosine hydroxyl group that promotes the ionization of the GSH
sulfhydryl group. The omega-class isozymes instead have a cysteine
residue (C32 in hGSTO1 and O2) in the active site that is oxidized
through the formation of an enzyme-GSH mixed disulfide with
the concomitant reduction of a co-substrate. Thus the omega class
isozymes function as thiol transferases/reductases. Reactions
catalysed include dehydroascorbate reduction and monomethy-
larsenate reduction [2,10–12].
Recently the role of omega-class GSTs in the disposition of a-
haloketones has been investigated. The a-haloketones are a class of
biologically active compounds that can enter the human body via
several pathways. Some a-haloketones have been identified as
metabolites of insecticides [13]. 2-Chloroacetophenone is an a-
haloketone used as a temporary incapacitating agent in tear-gas.
The non-enzymatic attack by GSH upon 2-chloroacetophenone
gives rise to S-(phenacyl)glutathione, which in turn is decomposed
reductively by hGSTO1-1 [14]. In contrast to other known
activities of the omega class GSTs, this reaction is unique to
hGSTO1-1 as hGSTO2-2 fails to show appreciable activity to this
class of substrate. This mechanism is thought to operate via
nucleophilic attack of the active site cysteine upon the cysteinyl
sulfur of the S-(phenacyl)glutathione, releasing acetophenone and
forming a mixed disulfide with the GSH moiety (Figure 1A).
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Physiologically, the enzyme is regenerated by the nucleophilic
attack of a second GSH molecule upon the mixed disulfide,
reducing the active-site cysteine and producing oxidized glutathi-
one (GSSG) (Figure 1B). b-Mercaptoethanol can substitute for the
second GSH for the regeneration of hGSTO1-1, increasing the
catalytic rate constant (kcat) by a factor of five [14]. A new
Figure 1. Chemical reactions and species. (A) Proposed reaction mechanisms for the (non enzymatic) formation of S-(phenacyl) glutathiones
and their (hGSTO1-1-catalyzed) reduction to acetophenones, and (B) the reduction of oxidised hGSTO1-1 by a second molecule of GSH. (C) chemical
structure of 4NPG.
doi:10.1371/journal.pone.0060324.g001
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compound, S-(4-nitrophenacyl)glutathione (4NPG) (Figure 1C),
has recently been synthesised that has a turnover rate that is
approximately 15 times higher, and displays a catalytic efficiency
more than 200 times higher than previously observed with S-
(phenacyl)glutathione [15]. In addition, it allows hGSTO1-1
activity to be measured spectrophotometrically by a characteristic
absorbance change at 305 nm.
In addition to activities involving GSH and its conjugates,
several classes of GST have been shown to exhibit ‘‘ligandin’’
activity, i.e., non-catalytic ligand binding. In the case of a squid
sigma- and a blood fluke mu-class GST, this has been
demonstrated to occur in the dimer interface [16,17]. In the
human pi-class GST, the ligandin site occupies part of the H-site
[18]. To date, no ligandin binding site has been structurally
characterized in an omega-class GST.
In this report, we have describe a crystal structure in which
GSSG is observed in the active site of an inactive hGSTO1-1
mutant (C32A), giving us a snapshot of enzyme regeneration
occurring. The same structure reveals the binding of 4NPG in the
dimer interface, revealing a non-catalytic ligandin binding site.
Methods
Protein was purified as described previously [15]. Briefly, the
hGSTO1-1 C32A mutant was expressed in Escherichia coli BL21
(DE3) cells as an N-terminal poly-His-tagged ubiquitin fusion
protein from the pHUE plasmid [19]. An initial purification step
on Ni-NTA agarose was followed by cleavage by a modified
mouse deubiquitylating enzyme [20] to yield enzyme with no
additional N-terminal residues. A second pass over Ni-NTA
agarose gave pure protein. In these experiments 5 mM DTT was
Figure 2. Electron density omit-maps of ligands. Binding sites in hGSTO1-1 for (A) GSSG and (B) the 4NPG are shown. The chemical entities and
surrounding residues are in stick representation. Electron density maps (mFO-DFC) calculated in Phenix are shown in green, contoured at 3 s. The
enzyme is shown in cartoon form.
doi:10.1371/journal.pone.0060324.g002
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substituted with 1 mM TCEP for the reducing agent in the final
dialysis buffer in order to prevent auto cleavage of the substrate in
subsequent crystal soaking experiments via formation of a GSH-
DTT mixed disulfide, in a manner analogous to the reaction with
b-mercaptoethanol described above. Datasets were collected from
two crystals grown under similar conditions. Both were grown via
the hanging-drop vapour diffusion method at 4uC. The reservoir
consisted of 2.2 M ammonium sulfate and 100 mM sodium
acetate pH 4.25 and 4.75 respectively. Crystallization drops
contained 1 ml hGSTO1-1 C32A at 32 mg/ml combined with
1 ml of reservoir solution. The crystals were then transferred to
pre-equilibrated soaking drops containing 2 ml of reservoir
solution and 2 ml of 10 mM 4NPG pH 7.0. Prior to this transfer,
one of the crystals was also soaked in a drop containing 2 ml of
reservoir together with 0.5 ml of GSH pH 7.5. Crystals were
subsequently cryoprotected via stepwise transfer to artificial
mother liquor containing 2.75 M lithium sulfate, 100 mM sodium
acetate pH 4.75 and glycerol at up to 15% (v/v).
Data was subsequently collected remotely at the SSRL using an
X-ray wavelength of 1.034375 A˚ (12 keV). X-ray data was
processed using software within the CCP4 suite [21]: the
diffraction images were processed and integrated using the
programs MOSFLM and SCALA. After phasing each dataset
separately using previously published complex with GSH (PDB
Figure 3. hGSTO1-1 ligand structure. The fold of hGSTO1-1 in complex with GSSG/4NPG is shown as a cartoon representation (cyan) with ligands
and amino acid residues shown in stick representation, coloured according to atom type. Side chains of significantly different conformation within
the GSH complex (PDB id: 1EEM) are overlayed (magenta carbon atoms). Polar interactions are shown with black dashed lines. (A) The active site of
hGSTO1-1, showing the complex of GSSG and associated conformational change in the ‘‘H-site’’. (B) The ligandin-binding site of hGSTO1-1 as viewed
from the point of view of the opposing monomer, which has been removed for clarity.
doi:10.1371/journal.pone.0060324.g003
Structural Insights into Omega-Class GSTs
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e60324
code: 1EEM) it was found that in spite of the slight differences in
soaking conditions, no significant differences could be observed in
the 2mFO-DFC or mFO-DFC electron density maps. POINTLESS
was therefore used to combine the two datasets and ascertain their
Laue symmetry before scaling with SCALA. The starting model
for refinement was again the previously published structure, (PDB
code: 1EEM) [2]. Molecular modelling of ligand into mFO-DFC
density was performed with COOT [22]. Ligand restraint
generation and structure refinement was performed with Phenix
[23]. The coordinates and X-ray structure factor amplitudes have
been deposited with the PDB (ID: 4IS0).
Results
The final structure contains one protomer (residues 4 to 241),
two sulfate molecules, one each of 4NPG, GSSG and DTT
molecules. A total of 140 water molecules were built into the
model. The asymmetric unit contains a single monomer: the
physiologically relevant dimer is produced by two-fold crystallo-
graphic symmetry. The crystals of hGSTO1-1 C32A mutant are
similar to that reported for the wild-type enzyme [2] (Table 1),
superimposing with a RMSD of 0.30 A˚ over 237 Ca atoms. Our
attempt to determine the structure of hGSTO1-1 in complex with
4NPG has revealed GSSG bound in the active site and 4NPG
bound at the dimer interface (Figure 2). The likely source of GSSG
is the non-enzymatic reaction of 4NPG with residual GSH in the
crystallization mixture. The GSSG dimer binds with one half of
the molecule in the G-site, with interactions the same as those
observed for reduced glutathione binding. The other half of the
GSSG dimer extends upwards into the H-site and is less well
ordered (Figure 2A). Indeed, interactions with this half of the
ligand are observed to be exclusively hydrophobic in character,
with only an internal hydrogen bond observed between the c-
glutamyl carbonyl and the glycinyl-amine of the G-site bound half
of the molecule. The lack of well-defined interactions with the
protein undoubtedly contributes to the relatively poor electron
density and high B-factors associated with the portion of the
molecule in the H-site. The binding of GSSG is associated with the
structural rearrangement of several amino acid side chains relative
to the previously published complex with glutathione [2]. H-site
residue Y229 has shifted to accommodate the c-glutamyl residue
and the indole group of W222 has rotated 180u (Figure 3A). In
addition, the nearby side chains of K57, I131 and R132 are
relatively poorly ordered.
4NPG binds in the dimer interface, deep within the cleft formed
between monomers. Because it sits on a crystallographic two-fold
axis, the electron density corresponds to two overlapping 4NPG
molecules at half-occupancy (Figure 2B). The glutathionyl
component of the molecule is relatively disordered. The bulk of
interactions of the protein are with the nitrophenacyl moiety
(Figure 3B). An exception is the glycinyl moiety of the compound,
observed adjacent to the c-glutamyl tail of GSSG, engaging in
a salt bridge interaction with the side chain of R37. The
nitrophenacyl functional group is observed pointing downwards
into the dimeric cleft. The binding site is too far from the active
site to be of catalytic relevance (the distance between the mutated
active-site C32A residue and 4NPG sulfur atom is about 17 A˚).
The 4NPG-binding site is largely hydrophobic, lined by residues
from helix a3 (A87, I88, C90, E91), the following loop (L103),
helix a4 (Q113, K114, L117) and helix a6 (M172, I173, L176).
The bottom of the pocket is formed by E91 and K114, which form
a salt bridge interaction. Relative to the structure of wild-type
hGSTO1-1 without ligand bound in the dimer interface, side-
chain movements are seen in K114 and E91, which move closer so
as to bind 4NPG with their aliphatic moieties and form the salt
bridge interaction. The binding mode of 4NPG in the dimer
interface may be representative of a ligandin-binding site similar to
that observed in other classes of GST. The binding of the anti-
Schistosomiasis drug Praziquantel to a mu-class GST from the
parasitic worm Schistosoma japonica [16], and the complex formation
of the GSH-conjugate, S-(3-iodobenzyl)glutathione with a sigma-
class GST of squid [17] are both reminiscent of the dimer interface
mode of binding observed for 4NPG (Figure 4). The residues
Table 1. Crystallographic statistics.
Diffraction data
Space group P3121
Unit cell Dimensions (A˚,u) a = 57.6, b = 57.6, c = 140.2, a= 90.0, b= 90.0, c= 120.0
Resolution limits (A˚) 40.6421.72 (1.8121.72){
Unique reflections 29,422 (4,197)
Completeness (%) 99.9 (99.1)
Multiplicity 16.2 (7.2)
R-merge (%) 8.1 (60.9)
I/sI 19.2 (2.3)
Refinement data
R-factor (%) 15.19
R-free (%) 20.07
RMSD from ideal geometry:
Bonds 0.011 A˚
Angles 1.424u
Chiral volumes 0.071 A˚3
Planar groups 0.007 A˚
{Values in parentheses refer to the highest resolution bin.
doi:10.1371/journal.pone.0060324.t001
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lining the binding site are well conserved across GSTO
homologues from a range of species (Figure 5).
Discussion
Some members of the GST family of enzymes were originally
identified as ‘‘ligandins’’, due to their apparent capacity to bind
a wide variety of large (.400 Da) lipophilic compounds such as
bile acids, fatty acids and certain drugs. This function was thought
to play a role in storage and transport of these compounds in the
aqueous phase of the cell [24]. The position of several of these
ligandin or ‘‘L-site’’ binding pockets have been identified
crystallographically in a broad spectrum of GSTs. While their
positions within the phi-class GST of Arabidopsis thaliana [25] and
the human pi-class GST [18] were observed to overlap with the H-
site, this is not always the case. The binding of the anti-
Schistosomiasis drug praziquantel to a mu-class GST of the
parasitic worm Schistosoma japonicum [16], S-(3-iodobenzyl)glu-
tathione to a squid sigma-class GST [17], and now, 4NPG to
hGSTO1-1 occur in the dimer interface and straddles the two-fold
axis. As can be observed in Figure 4, the location of the ligand
along the two-fold axis appears to be related to the width of the
interface: hGSTO1-1 has the widest interface and the deepest
ligandin-site of these GSTs. This ligandin site in hGSTO1-1 may
be the binding site for non-competitive inhibitors. (+)-a-Tocoph-
erol succinate has been reported to be a non-competitive inhibitor
of the monomethylarsonate (V) reductase activity of hGSTO1-1
with an IC50 of 4 mM [26]. Although soaking experiments with
(+)-a-tocopherol succinate into crystals of hGSTO1-1 have not
revealed the binding location (data not shown), it appears likely
that it is congruent with the ligandin site described here. Binding
of (+)-a-tocopherol succinate to hGSTO1-1 in crystals is most
likely precluded by the limited solubility of the compound in
crystallization solutions.
It is instructive to compare the newly identified L-site with
features in other omega-class and related GSTs. Residues in
hGSTO1-1 binding the 4-Nitrophenacyl moiety are conserved or
conservatively substituted in homologues from other species, and
in hGSTO2 [10] but not more distantly related sequences
(Figure 5). Recently described GSTs related to hGSTO1-1 may
contain putative L-sites at identical locations. These include
Bombyx mori GSTO3-3 [27], Sphingobium sp. SYK-6 LigG [28],
Phanerochaete chrysosporium GSTO3-3 [29] and Phanerochaete chrysos-
porium GSTFuA [30]. While regions in the Bombyx mori GSTO3-3
and Sphingobium sp. SYK-6 LigG equivalent to the hGSTO1-1 L-
site appear more occluded (Figure 6B, C), ligandin activity at these
sites cannot be ruled out. The situation in Phanerochaete chrysosporium
GSTO3-3 and GSTFuA is significantly altered due to the
fundamentally different nature of dimerization interactions in
these GSTs: the putative L-site regions are no longer on the dimer
interfaces and are more solvent exposed (Figure 6D, E). It is
noteworthy that ligandin activity has been reported in GSTFuA1.
This GST binds 8-anilo-1-naphthalenesulfonicacid (8ANS) non-
competitively with substrates expected to bind in the H-site, but
competitively with respect to GSH, and it has been proposed that
the L-site in this GST co-localizes with the G-site [30].
Like the Omega-class GSTs, the beta-class GSTs from bacteria
feature an active-site cysteine that forms a mixed disulfide with
GSH, as demonstrated in the crystal structure of the Proteus
mirabilis enzyme [31]. Therefore, in common with the Omega-
class GSTs, binding of a second GSH molecule is a necessary
physiological step for the regeneration of the reduced enzyme.
Binding of GSH in the H-site of the Ochrobactrum anthropi beta-class
GST has been observed [32], however, a mixed disulfide between
Figure 4. Structures of GSTs with ligands bound in the dimer
interface. Monomers are shown as ribbons, ligands as van der Waals
surfaces. (A) Squid sigma-class GST with S-(3-iodobenzyl)glutathione
[17] (PDB ID: 2GSQ). (B) praziquantel to a mu-class GST of the parasitic
worm Schistosoma japonica (PDB ID: 1GTB) [16] (C) 4NPG bound to
hGSTO1-1 (this work).
doi:10.1371/journal.pone.0060324.g004
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the Ochrobactrum anthropi beta-class GST and GSH has not yet been
observed [33], so the function of this second GSH-binding
phenomenon remains an open question. This is not the case for
Omega-class GSTs, where well-defined catalytic reactions result in
oxidation of the enzyme, which must then be reduced. The H-sites
of beta- and omega-class GSTs differ substantially and this is
reflected in the distinct modes of binding of GSH. The second
GSH molecule in the H-site of hGSTO1-1 is relatively disordered,
with no specific hydrogen bonding interactions between enzyme
and substrate. This implies that there is little specificity for GSH in
Figure 5. Sequence alignment of representative hGSTO1 homologues. The species and genbank identifiers of the sequences are Hs (Homo
sapiens, O1 gi: 4758484; O2 gi: 34922124) Rn (Rattus norvegicus, gi: 56090550), Tg (Taeniopygia guttata, gi: 224052779), Xl (Xenopus laevis, gi:
147907264), Ss (Salmo salar, gi: 213511516), Bm (Bombyx mori, gi: 87248151), Pa (Pectobacterium atrosepticum, gi: 50120521), Pc (Phanerochaete
chrysosporium, gi: 193161505). Conserved or conservatively substituted residues are highlighted in yellow (G-site), green (H-site residues contacting
the second GSH moiety), and magenta (L-site residues in the dimer interface).
doi:10.1371/journal.pone.0060324.g005
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this part of the reaction. Indeed, b-mercaptoethanol can substitute
for the second GSH molecule in the regeneration of hGSTO1-1
[14]. The rearrangement of the H-site to accommodate the second
GSH molecule helps explain the slower rate of reaction with this
compound as reducing agent relative to b-mercaptoethanol, which
is smaller and would appear less likely to require shifts in H-site
residues in order to bind. From the structure, possible mechanisms
for the activation of the second GSH molecule can be proposed.
The backbone amide nitrogen group of F34 (in the active-site
‘‘CPFA loop’’) is the only moiety that could potentially donate
a hydrogen bond to the sulfur atom of the second GSH molecule.
Although the NH to S distance in the complex with GSSG is
4.6 A˚, this could plausibly be shorter prior to GSSG formation.
Furthermore, the distribution of positive charges in the H-site
(along with the dipole moment of helix a2 over which the
sulfhydryl would be positioned) will favour deprotonation of the
second GSH molecule, which can then attack the mixed disulfide.
It is noteworthy that experimentally determined structures of
glutaredoxins and thioltransferases contain loops structurally
equivalent to the CPFA loop in hGSTO1-1. For example, in the
crystal structure of human thiol-transferase is an active site CPFC
motif [34] structurally analogous to CPFA in hGSTO1-1. As
glutaredoxins form mixed disulfides with GSH, and can be
reduced by a second GSH molecule with the formation of GSSG
[35], this points to a conserved role for the active-site loop and
possibly of the backbone F34 amide in activating thiol groups for
enzyme reduction.
Conclusion
A snapshot of hGSTO1-1 in the process of being regenerated
has been observed by crystallography. We show that a GSSG
molecule can bind in the active site, with one half of the molecule
in the canonical G-site, and the other half in the H-site. There are
few specific interactions of the glutathionyl moiety bound in the H-
site. This apparent lack of specificity gives a possible explanation as
to why other sulhydyl containing compounds can substitute for
GSH in the recycling of oxidized hGSTO1-1. We have further
identified a potential non-catalytic ligand-binding site in the dimer
interface that may be the binding location of uncompetitive
inhibitors such as tocopherol.
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